31st-Jan-2012 09:57
Source: NSE
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange that at the meeting of the Board of Directors held on January 30, 2012, Dr. Brian W. Tempest and Mr. Bernard Munos have been appointed as Add...
30th-Jan-2012 16:30
Source: BSE
Glenmark- Outcome of Board Meeting
Glenmark Pharmaceuticals Ltd has informed BSE that at the meeting of the Board of Directors held on January 30, 2012, Dr. Brian W. Tempest and Mr. Bernard Munos have been appointed as Additional Direc...
30th-Jan-2012 16:20
Source: NSE
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 30, 2012, titled "Glenmark''s consolidated revenue increases by 37.73% to Rs. 10,310.86 mn for Q3 FY ...
30th-Jan-2012 16:18
Source: NSE
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2011 as follows: Net Sales of Rs. 39688 lacs for quarter ending on 31-DEC-20...
30th-Jan-2012 16:17
Source: NSE
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2011.
20th-Jan-2012 13:16
Source: BSE
Glenmark- Q3 results on Jan 30, 2012
Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 30, 2012, to consider and approve the Un-Audited Financial Results for the...